TrialJournal of neurovirology2006

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Karl Goodkin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.